Baylor Genetics to Highlight Multimodal Solutions for Rare Disease Diagnostics at Festival of Genomics, Biodata & AI
Baylor Genetics will be participating in the Festival of Genomics, Biodata & AI, taking place June 3–4 in Boston, bringing together leaders advancing genomic medicine.
Dr. Christine Eng, Chief Medical Officer and Chief Quality Officer at Baylor Genetics, will present “Innovative Multimodal Solutions for Rare Disease Diagnostics” on June 3 from 2:40–3:10 PM (Innovation Stage).
The session will highlight how Baylor Genetics integrates Whole Genome Sequencing (WGS) with complementary technologies—including RNA Sequencing, long-read sequencing, and optical genome mapping—to identify complex variants that conventional approaches may miss. Through real-world case examples, attendees will learn how this patient-centered, multimodal approach helps deliver more answers and guide patient care.
Learn more about our genome-first, multimodal approach here.
